Leading medical organizations team up to bring new TB treatments to those in need
03/19/2015. International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).
By 2019, endTB will provide access to two new anti-TB drugs (bedaquiline and delamanid), for 2,600 MDR-TB patients in 16 countries. These are the first new anti-TB drugs developed in over 50 years and these drugs offer new hope to patients suffering from MDR-TB.
Read the article on MSF website
Related Articles
Countries in crisis: rethinking the role of development aid
02/23/2016. On the occasion of the 3rd National Conference Humanitarian the CEO of the French Development Agency invites us to consider development aid as an investment.
Race against the clock to run Aleppo
02/07/2016. Support networks Syrians are busy rescuing Aleppo residents before the city is encircled by the troops of Bashar Assad. The loyalist offensive provokes a stampede can.
ICRC appoints new director-general
10/31/2019. The Assembly of the International Committee of the Red Cross (ICRC) has appointed Robert Mardini to the post of director-general.
